Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

US Stocks Higher; Nasdaq Jumps 100 Points

Author: Avi Kapoor | January 22, 2024 11:15am

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday.

Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose 0.71% to 15,420.00. The S&P 500 also rose, gaining, 0.49% to 4,863.49.

Check This Out: Top 5 Health Care Stocks That May Crash This Month

 

Leading and Lagging Sectors

 

Real estate shares rose by 1.4% on Monday.

In trading on Monday, consumer staples shares fell by 0.2%.

 

Top Headline

 

US leading index fell 0.1% for December, versus analysts’ expectations for a 0.5% decline.

 

Equities Trading UP

 

Sagimet Biosciences Inc. (NASDAQ:SGMT) shares shot up 155% to $17.37 after the company announced denifanstat in the Phase 2b FASCINATE-2 clinical trial achieved statistically significant results on the primary and multiple secondary endpoints.

Shares of Rail Vision Ltd. (NASDAQ:RVSN) got a boost, surging 50% to $2.07. Rail Vision said its main line system has successfully obtained formal certifications for critical European Union railway standards.

Fisker Inc. (NYSE:FSR) shares were also up, gaining 33% to $1.04. Fisker filed a Form 8-K with the Securities and Exchange Commission regarding amendments with its 2025 convertible notes investor.

 

Equities Trading DOWN

 

Virios Therapeutics, Inc. (NASDAQ:VIRI) shares dropped 33% to $0.5411.
Virios Therapeutics announced plans to advance development of IMC-2 as treatment for symptoms associated with long-COVID.

Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) were down 32% to $3.06. Processa Pharmaceuticals recently announced plans to expand the development of Next Generation Capecitabine into the treatment of advanced or metastatic breast cancer.

Nuvve Holding Corp. (NASDAQ:NVVE) was down, falling 22% to $2.9908. Nuvve recently announced a 1-for-40 reverse stock split.

Also Check This Out: 3 Minutes To Boost Your Earnings: 3 Stocks With Over 5% Dividend Yields In Utilities Sector From Wall Street's Most Accurate Analysts

 

Commodities

 

In commodity news, oil traded up 1.2% to $74.28 while gold traded down 0.2% at $2,025.40.

Silver traded down 1.9% to $22.28 on Monday while copper fell 0.6% to $3.7640.

 

Euro zone

 

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.7%, London’s FTSE 100 rose 0.2% while Spain’s IBEX 35 Index rose 1.1% The German DAX rose 0.6% French CAC 40 rose 0.6% while Italy’s FTSE MIB Index fell 0.3%.

 

Asia Pacific Markets

 

Asian markets closed mixed on Monday, with Japan’s Nikkei 225 gaining 1.62%, Hong Kong’s Hang Seng Index falling 2.27% and China’s Shanghai Composite Index declining 2.68%. India’s S&P BSE Sensex, meanwhile, fell 0.36%.

The annual inflation rate in Hong Kong eased to 2.4% in December from 2.6% in the prior month. The People's Bank of China kept its lending rates unchanged at the January fixing.

 

Economics

 

US leading index fell 0.1% for December, versus analysts’ expectations for a 0.5% decline.

Now Read This: How To Earn $500 A Month From AT&T Stock Ahead Of Q4 Print

Posted In: FSR NVVE PCSA RVSN SGMT VIRI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist